Accueil>>Signaling Pathways>> Tyrosine Kinase>> Spleen Tyrosine Kinase (Syk)>>Cevidoplenib

Cevidoplenib (Synonyms: SKI-O-703)

Catalog No.GC63429

Le cévidoplénib est un inhibiteur disponible par voie orale de la tyrosine kinase de la rate (Syk), avec des activités anti-inflammatoires et immunomodulatrices potentielles.

Products are for research use only. Not for human use. We do not sell to patients.

Cevidoplenib Chemical Structure

Cas No.: 1703788-21-9

Taille Prix Stock Qté
10mM (in 1mL DMSO)
293,00 $US
En stock
5mg
266,00 $US
En stock
10mg
420,00 $US
En stock
25mg
805,00 $US
En stock
50mg
1 260,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Cevidoplenib is an orally active spleen tyrosine kinase (Syk) inhibitor with potential anti-inflammatory and immunomodulatory effects[1].

References:
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 31, No. 4, 2017.

Avis

Review for Cevidoplenib

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Cevidoplenib

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.